Genetically encoded fluorescence indicators, such as the GCaMP family calcium indicators, in combination with the advancement of microscopy, have revolutionized many fields in biomedical research. They allow for simultaneous in vivo recording of a large number of cells with genetically defined cell types, and linking cellular events to animal behavior [1] . In this meeting, we will present our work in the development of genetically encoded indicators for monitoring intracellular events downstream of neuromodulation, and implementing in vivo imaging of these indicators in combination with two-photon fluorescent lifetime imaging microscopy (2pFLIM) [2].
In the brain, there are two primary modes of chemical communication between neurons: fast synaptic transmission, such as that mediated by glutamate and GABA, and slow synaptic transmission, such as that mediated by norepinephrine (NE), dopamine (DA), serotonin, and opioids [3] . Slow synaptic transmission, also known as neuromodulation, regulates the excitability, synaptic plasticity and other essential aspects of neuronal function. While great strides have been made in improvement of multielectrode recording, voltage imaging and calcium imaging, allowing for examining the dynamics of neuronal electrical activities that are controlled directly by fast synaptic transmission in behaving animals, little is known about the precise neuromodulatory events that occur in living animals since the imaging modality to reliably record the relevant activities triggered by neuromodulation at single cell resolution in vivo is not well established. The cyclic AMP (cAMP)/protein kinase A (PKA) pathway is a common downstream signal transduction pathway for the major neuromodulators [4] . Imaging the activity of the cAMP/PKA pathway in individual neurons, therefore, provides readout for neuromodulatory events in large neuronal population, in analogous to imaging calcium for fast transmission events.
Although genetically encoded cAMP/PKA indicators have been used in vitro [5] , their applications under the more challenging in vivo imaging conditions have been difficult. We choose to image and optimize the indicators using 2pFLIM for two considerations. First, because 2pFLIM measures only the lifetime of the donor in a FRET fluorophore pair, it does not suffer from wavelength-dependent light scattering, and provides stable measurements across different tissue depths. Second, 2pFLIM measurements only occurs in one color channel [6, 7] . In conjunction with the use of a low quantum yield acceptor, this frees the other color channel for multiplexed measurement of orthogonal neuronal properties (e.g., simultaneous imaging of a calcium indicator or a morphological marker). We started by screening for the best existing PKA indicators [8] for their responses to NE in organotypic slice culture preparations that have the potential to inform the indicators' performance in vivo (Figure 1 ). By using subcellular targeting strategy, we further developed a variant (named tAKARα) with much increased sensitivity and a broadened dynamic range (Figure 2 ). This indicator enabled the detection of PKA activation by NE at physiologically-relevant concentrations and kinetics, and by optogenetically released endogenous DA. In vivo longitudinal 2pFLIM imaging of tAKARα tracked bidirectional PKA activities in individual neurons in awake mice, and revealed that locomotion elicits cell-specific neuromodulator 
